These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20554441)

  • 21. Revealing promiscuous drug-target interactions by chemical proteomics.
    Bantscheff M; Scholten A; Heck AJ
    Drug Discov Today; 2009 Nov; 14(21-22):1021-9. PubMed ID: 19596079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
    Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
    J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network modeling of signal transduction: establishing the global view.
    Kestler HA; Wawra C; Kracher B; Kühl M
    Bioessays; 2008 Nov; 30(11-12):1110-25. PubMed ID: 18937364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular networks and system-level properties.
    Alberghina L; Höfer T; Vanoni M
    J Biotechnol; 2009 Nov; 144(3):224-33. PubMed ID: 19616593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding the target after screening the phenotype.
    Hart CP
    Drug Discov Today; 2005 Apr; 10(7):513-9. PubMed ID: 15809197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biological networks modulated by complement.
    Mastellos D; Andronis C; Persidis A; Lambris JD
    Clin Immunol; 2005 Jun; 115(3):225-35. PubMed ID: 15893689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.
    Janga SC; Tzakos A
    Mol Biosyst; 2009 Dec; 5(12):1536-48. PubMed ID: 19763339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels.
    Yin N; Pei J; Lai L
    Mol Biosyst; 2013 Jun; 9(6):1381-9. PubMed ID: 23478789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction networks: from protein functions to drug discovery. A review.
    Chautard E; Thierry-Mieg N; Ricard-Blum S
    Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding site detection and druggability index from first principles.
    Seco J; Luque FJ; Barril X
    J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale prediction of drug-target relationships.
    Kuhn M; Campillos M; González P; Jensen LJ; Bork P
    FEBS Lett; 2008 Apr; 582(8):1283-90. PubMed ID: 18291108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clustering and its application in multi-target prediction.
    Liu W; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A data integration approach for cell cycle analysis oriented to model simulation in systems biology.
    Alfieri R; Merelli I; Mosca E; Milanesi L
    BMC Syst Biol; 2007 Aug; 1():35. PubMed ID: 17678529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
    Tan L; Batista J; Bajorath J
    Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined approach to drug metabolism and toxicity assessment.
    Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
    Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential network expression during drug and stress response.
    Cabusora L; Sutton E; Fulmer A; Forst CV
    Bioinformatics; 2005 Jun; 21(12):2898-905. PubMed ID: 15840709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of cell-based label-free technology in drug discovery.
    Xi B; Yu N; Wang X; Xu X; Abassi YA
    Biotechnol J; 2008 Apr; 3(4):484-95. PubMed ID: 18412175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.